FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

28024411000001103: Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Dec 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
88682501000001115 Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106048701000001117 Vokanamet 50mg/1000mg tablets (Napp Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Is a Canagliflozin 50mg / Metformin 1g tablets true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Canagliflozin hemihydrate false Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Is a Vokanamet true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has active ingredient Metformin true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has active ingredient Canagliflozin true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Canagliflozin hemihydrate true Inferred relationship Existential restriction modifier
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Has basis of strength substance Canagliflozin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) 60 tablet Has AMP True Vokanamet 50mg/1000mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start